Drug intelligence / Profile preview

Dimethyl sulfoxide

Development stage
Approved
Modality
Small Molecules
Administration
Intravesical, Topical, Intravenous
01

Overview

Dimethyl sulfoxide (DMSO) is a highly polar organic liquid and small molecule used as a pharmaceutical agent, chemical solvent, and cryoprotectant. It is approved by the FDA for intravesical use in the treatment of interstitial cystitis (chronic inflammatory bladder disease). DMSO has notable membrane penetration properties, enhancing the absorption of other drugs through biological membranes. Its pharmacological activities include anti-inflammatory, analgesic, antioxidant effects, and it is also used to protect tissues during cryopreservation. The mechanism of action is not fully understood but involves reversible inhibition of mitogen‑activated extracellular signal‑regulated kinase 1 (MEK1) and MEK2; it also acts as an antioxidant and downregulates targets such as interleukin‑5 receptor subunit alpha, mucin‑16, and Myc proto-oncogene protein. At the cellular level, DMSO increases membrane fluidity at low concentrations and induces pore formation at higher concentrations—mechanisms that underlie its ability to enhance drug delivery through skin or cell membranes[3][4][5][6].

Brand names
Rimso-50Rimso50Rimso 50
Other names
DMSODimethylis SulfoxidumDimethyl SulphoxideDimethylsulfoxideDiméthylsulfoxydeDimetilsulfóxidoMethyl SulphoxideSulfoxyde de DiméthylSulphinybismethane
02

Targets

MEK1 (Dual specificity mitogen-activated protein kinase kinase 1)MEK2 (Dual specificity mitogen-activated protein kinase kinase 2)

Beyond the preview

Go deeper on Dimethyl sulfoxide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dimethyl sulfoxide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call